你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: call_new 0574-87917803
NCI-H1819 [H1819]
NCI-H1819 [H1819]
规格:
货期:
编号:TS211337
品牌:Testobio
产品名称: NCI-H1819 H1819
商品货号: TS211337
Organism: Homo sapiens, human
Tissue: lung; derived from metastatic site: lymph node
Product Format: frozen
Culture Properties: mixed, adherent and suspension
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: adenocarcinoma
Age: 55 years
Gender: female
Ethnicity: Caucasian
Storage Conditions: liquid nitrogen vapor phase
Derivation:
The cell line was established from a patient who had received prior chemotherapy and radiation therapy.xa0
Clinical Data:
55 years
Caucasian
female
The patient was a smoker (80 pack years).
Complete Growth Medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001.To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 5%
Subculturing:

Volumes used in this protocol are for a 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.

  1. Remove culture medium, which contains suspended cells, to a centrifuge tube.
  2. Briefly rinse the cell layer with Ca++/Mg++ free Dulbeccos phosphate-buffered saline (D-PBS) or 0.25% (w/v) Trypsin-0.53 mM EDTA solution to remove all traces of serum, which contains trypsin inhibitor.
  3. xa0Add 2.0 to 3.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 10 minutes).

Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach.xa0 Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

  1. Add 6.0 to 8.0 mL of complete growth medium and aspirate cells by gently pipetting.xa0
  2. To remove trypsin-EDTA solution, transfer cell suspension to the centrifuge tube containing the medium and cells from step #1 and centrifuge at approximately 125 x g for 5 to 10 minutes.
  3. Discard supernatant and resuspend cells in fresh growth medium.xa0 Add appropriate aliquots of cell suspension to new culture vessels.
  4. Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:3 is recommended

Medium Renewal: Every 2 to 3 days.xa0

Cryopreservation:
Freeze medium: Culture medium, 92.5%; DMSO, 7.5%
Storage temperature: liquid nitrogen vapor phase
Culture Conditions:
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37°C
STR Profile:
Amelogenin:X
CSF1PO:12,14
D13S317:11
D16S539:10
D5S818:10,12
D7S820:9,10
THO1:9.3
TPOX:8
vWA: 16
This cell line was isolated from the same patient as was CRL-5887.
Name of Depositor: AF Gazdar, JD Minna
Deposited As: Homo sapiens
Year of Origin: January, 1988
References:

NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.

首页 > 产品中心 > 微生物培养 > 菌株 > null > NCI-H1819 [H1819]

NCI-H1819 [H1819]

  • 货号: TS211337
  • 好评
询价
  • 品牌 : TESTOBIO
产品名称: NCI-H1819 H1819
商品货号: TS211337
Organism: Homo sapiens, human
Tissue: lung; derived from metastatic site: lymph node
Product Format: frozen
Culture Properties: mixed, adherent and suspension
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: adenocarcinoma
Age: 55 years
Gender: female
Ethnicity: Caucasian
Storage Conditions: liquid nitrogen vapor phase
Derivation:
The cell line was established from a patient who had received prior chemotherapy and radiation therapy.xa0
Clinical Data:
55 years
Caucasian
female
The patient was a smoker (80 pack years).
Complete Growth Medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001.To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 5%
Subculturing:

Volumes used in this protocol are for a 75 cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.

  1. Remove culture medium, which contains suspended cells, to a centrifuge tube.
  2. Briefly rinse the cell layer with Ca++/Mg++ free Dulbeccos phosphate-buffered saline (D-PBS) or 0.25% (w/v) Trypsin-0.53 mM EDTA solution to remove all traces of serum, which contains trypsin inhibitor.
  3. xa0Add 2.0 to 3.0 mL of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 10 minutes).

Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach.xa0 Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

  1. Add 6.0 to 8.0 mL of complete growth medium and aspirate cells by gently pipetting.xa0
  2. To remove trypsin-EDTA solution, transfer cell suspension to the centrifuge tube containing the medium and cells from step #1 and centrifuge at approximately 125 x g for 5 to 10 minutes.
  3. Discard supernatant and resuspend cells in fresh growth medium.xa0 Add appropriate aliquots of cell suspension to new culture vessels.
  4. Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:3 is recommended

Medium Renewal: Every 2 to 3 days.xa0

Cryopreservation:
Freeze medium: Culture medium, 92.5%; DMSO, 7.5%
Storage temperature: liquid nitrogen vapor phase
Culture Conditions:
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37°C
STR Profile:
Amelogenin:X
CSF1PO:12,14
D13S317:11
D16S539:10
D5S818:10,12
D7S820:9,10
THO1:9.3
TPOX:8
vWA: 16
This cell line was isolated from the same patient as was CRL-5887.
Name of Depositor: AF Gazdar, JD Minna
Deposited As: Homo sapiens
Year of Origin: January, 1988
References:

NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.

合作单位: